These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35369761)

  • 21. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epilepsy of Infancy With Migrating Focal Seizures: Identification of
    Mao X; Bruneau N; Gao Q; Becq H; Jia Z; Xi H; Shu L; Wang H; Szepetowski P; Aniksztejn L
    Front Cell Neurosci; 2020; 14():1. PubMed ID: 32038177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
    Gribkoff VK; Winquist RJ
    Biochem Pharmacol; 2023 Feb; 208():115413. PubMed ID: 36646291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coupling of Slack and Na
    Yuan T; Wang Y; Jin Y; Yang H; Xu S; Zhang H; Chen Q; Li N; Ma X; Song H; Peng C; Geng Z; Dong J; Duan G; Sun Q; Yang Y; Yang F; Huang Z
    Elife; 2024 Jan; 12():. PubMed ID: 38289338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
    Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
    Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
    Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
    Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.
    Miziak B; Czuczwar SJ
    Expert Opin Drug Discov; 2022 Dec; 17(12):1313-1328. PubMed ID: 36408599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted treatment of migrating partial seizures of infancy with quinidine.
    Bearden D; Strong A; Ehnot J; DiGiovine M; Dlugos D; Goldberg EM
    Ann Neurol; 2014 Sep; 76(3):457-61. PubMed ID: 25042079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K
    Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL
    Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
    Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
    Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.
    Qunies AM; Mishra NM; Spitznagel BD; Du Y; Acuña VS; David Weaver C; Emmitte KA
    Bioorg Med Chem Lett; 2022 Nov; 76():129013. PubMed ID: 36184030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.
    Gras M; Bearden D; West J; Nabbout R
    Epilepsia Open; 2024 Aug; 9(4):1176-1191. PubMed ID: 39093319
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Iraci N; Carotenuto L; Ciaglia T; Belperio G; Di Matteo F; Mosca I; Carleo G; Giovanna Basilicata M; Ambrosino P; Turcio R; Puzo D; Pepe G; Gomez-Monterrey I; Soldovieri MV; Di Sarno V; Campiglia P; Miceli F; Bertamino A; Ostacolo C; Taglialatela M
    J Med Chem; 2024 Jun; 67(11):9124-9149. PubMed ID: 38782404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.
    Xu D; Chen S; Yang J; Wang X; Fang Z; Li M
    Br J Clin Pharmacol; 2022 Dec; 88(12):5096-5112. PubMed ID: 35940594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ALS-Associated Mutant SOD1 Rapidly Suppresses KCNT1 (Slack) Na
    Zhang Y; Ni W; Horwich AL; Kaczmarek LK
    J Neurosci; 2017 Feb; 37(8):2258-2265. PubMed ID: 28119399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
    Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
    Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCNT1 Channel Blockers: A Medicinal Chemistry Perspective.
    Di Matteo F; Mancuso F; Turcio R; Ciaglia T; Stagno C; Di Chio C; Campiglia P; Bertamino A; Giofrè SV; Ostacolo C; Iraci N
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38931004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
    Milligan CJ; Li M; Gazina EV; Heron SE; Nair U; Trager C; Reid CA; Venkat A; Younkin DP; Dlugos DJ; Petrovski S; Goldstein DB; Dibbens LM; Scheffer IE; Berkovic SF; Petrou S
    Ann Neurol; 2014 Apr; 75(4):581-90. PubMed ID: 24591078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
    Poisson K; Wong M; Lee C; Cilio MR
    Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinidine in the treatment of KCNT1-positive epilepsies.
    Mikati MA; Jiang YH; Carboni M; Shashi V; Petrovski S; Spillmann R; Milligan CJ; Li M; Grefe A; McConkie A; Berkovic S; Scheffer I; Mullen S; Bonner M; Petrou S; Goldstein D
    Ann Neurol; 2015 Dec; 78(6):995-9. PubMed ID: 26369628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.